Related Experiment Video
Updated: Jun 28, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
Suppression of beta-catenin signaling by liver X receptor ligands
Shigeyuki Uno1, Kaori Endo, Yangsik Jeong
1Division of Biochemistry, Department of Biomedical Sciences, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan.
Abstract:
The nuclear receptors liver X receptor (LXR) alpha and LXRbeta serve as oxysterol receptors and play an important role in the regulation of lipid metabolism. We investigated the potential effects of LXRs on pathways of colon carcinogenesis and found that LXR activation suppresses the transactivation activity of beta-catenin, a key molecule in Wnt signaling. LXRalpha and LXRbeta inhibited beta-catenin transactivation of T cell factor-mediated transcription in a ligand-dependent manner. LXR activation suppressed an oncogenic beta-catenin, which has phosphorylation site mutations, and did not change beta-catenin protein expression in cells. In contrast, beta-catenin enhanced LXR transactivation activity. Nuclear LXRs and beta-catenin were coimmunoprecipitated in colon cancer HCT116 cells, and in vitro experiments showed that LXRs bind directly to the Armadillo repeat region of beta-catenin in a ligand-independent manner. LXR ligand decreased mRNA expression of beta-catenin targets, MYC, MMP7 and BMP4, and recruited LXRs to MYC and MMP7 promoters. Transfection of a dominant negative LXR to HCT116 cells and experiments using LXR-null cells showed the involvement of cellular LXRs in beta-catenin suppression and proliferation inhibition. The results show lipid-sensing receptor LXRs regulate the beta-catenin activity and cellular proliferation.
Insights
Liver X receptors (LXRs) regulate lipid metabolism and colon cancer pathways. LXR activation suppresses beta-catenin activity, inhibiting cell proliferation by targeting key genes.
Area of Science:
- Molecular Biology
- Oncology
- Lipid Metabolism
Background:
- Nuclear receptors liver X receptor (LXR) alpha and LXRbeta are key regulators of lipid metabolism.
- The Wnt signaling pathway, involving beta-catenin, is crucial in colon carcinogenesis.
- Understanding the interplay between LXRs and beta-catenin is vital for cancer research.
Purpose of the Study:
- To investigate the effects of LXRs on colon carcinogenesis pathways.
- To determine how LXR activation influences beta-catenin transactivation activity.
- To elucidate the molecular mechanisms underlying LXR-beta-catenin interactions in colon cancer.
Main Methods:
- Ligand-dependent and independent assays to assess LXR and beta-catenin interactions.
- Co-immunoprecipitation in HCT116 colon cancer cells.
- Analysis of mRNA expression of beta-catenin target genes (MYC, MMP7, BMP4).
- Experiments using dominant-negative LXR and LXR-null cells.
Main Results:
- LXR activation suppressed beta-catenin transactivation activity in a ligand-dependent manner.
- LXRs directly bind to the Armadillo repeat region of beta-catenin.
- LXR activation decreased MYC, MMP7, and BMP4 mRNA expression and recruited LXRs to their promoters.
- Cellular LXRs were involved in beta-catenin suppression and inhibition of colon cancer cell proliferation.
Conclusions:
- Lipid-sensing receptors LXRs play a regulatory role in beta-catenin activity and cellular proliferation.
- LXR activation presents a potential therapeutic strategy for colon cancer by modulating Wnt signaling.
- The findings highlight a novel mechanism linking lipid metabolism and colon cancer progression.
More Related Videos
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
TGF - β Signaling Pathway
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Regulation of Angiogenesis and Blood Supply
